Bronchial Thermoplasty (BT) improves asthma-related quality of life for people with severe asthma by reducing asthma attacks1

BT reduces asthma attacks by reducing airway smooth muscle

With less smooth muscle, the airways constrict less, reducing asthma attacks and making breathing easier.

See how Bronchial Thermoplasty works to reduce asthma attacks

Fewer asthma attacks means less need for the associated oral steroid treatment—and its side effects.

How BT Works

BT delivered by the Alair™ System is clinically safe and effective with results proven to last at least 5 years

Clinically proven to reduce asthma exacerbations

Clinically proven to reduce ER visits

Supported by 5 years of clinical safety data

32%

84%

5

decrease

reduction

years

in severe asthma attacks1

in emergency room visits for respiratory-related symptoms1

Reductions in asthma attacks and ER visits were shown to extend through a 5-year follow-up period.2

Clinically proven to reduce asthma exacerbations

32%

decrease

in severe asthma attacks1

Clinically proven to reduce ER visits

84%

reduction

in emergency room visits for respiratory-related symptoms1

Supported by 5 years of clinical safety data

5

years

Reductions in asthma attacks and ER visits were shown to extend through a 5-year follow-up period.2

BT complements your current treatment options to significantly improve your asthma-related quality of life

79%

79% of patients who were treated with BT reported a
significant improvement in their asthma-related quality of life1

Bronchial Thermoplasty is delivered by the Alair System in 3 outpatient sessions performed by a BT-Certified pulmonologist

  • Each session treats a different part of the lung to ensure safety
  • During the procedure a carefully controlled device delivers mild heat to the smooth muscle of the airways in your lungs, reducing the amount of excessive smooth muscle
  • No incision is needed; BT is performed with a bronchoscope inserted through the nose or mouth
  • When your BT treatment is complete, you will return to your regular asthma-treating physician to continue managing your asthma

Risks, Side Effects, and Other Important Information

As with any procedure, there are risks, and individual results may vary. The most common side effect of BT is temporary worsening of respiratory-related symptoms. This side effect typically occurs within a day of the procedure and resolves within 7 days on average with standard care. There is a small (3.4% per procedure) risk of these symptoms requiring hospitalization.1

Your BT treatment will be delayed if you currently have any of the following conditions:

  • An active respiratory infection
  • A bleeding disorder
  • An asthma attack in the past 14 days
  • An increased or decreased dose of the oral steroids for asthma in the past 14 days
  • Your doctor says you cannot stop taking the following medications prior to the BT procedure: anticoagulants, antiplatelet agents, aspirin, or non-steroidal anti-inflammatory medications (NSAIDS)

You are not a candidate for BT if you:

  • Are under 18 years old
  • Have a pacemaker, internal defibrillator, or other implantable electronic device
  • Have a known sensitivity to medications required to perform bronchoscopy, including lidocaine, atropine, and benzodiazepines
  • Have been treated previously with BT

The benefits of BT are Long Lasting2

Richard Jefferson

Professional Basketball Player

2016 World Champion

Severe Asthma sufferer

Richard Jefferson is a BT patient and a paid spokesperson of the Alair™ System

How much does asthma stop
you from doing the things you wish you could do?

Take the Asthma Impact Survey

Take the FREE Asthma Assessment

The Alair Bronchial Thermoplasty System is indicated for the treatment of severe persistent asthma in patients 18 years and older whose asthma is not well controlled with inhaled corticosteroids and long-acting beta-agonists.

As with any procedure, there are risks, and individual results may vary. The most common adverse event of BT is a temporary worsening of respiratory-related symptoms. These events typically occur within one day of the BT procedure and usually resolve within a week with standard care. There is a small risk (3.4% per procedure) that symptoms may require hospitalization.2

References:

  1. Castro M, et al, for the AIR2 Trial Study Group. Am J Respir Crit Care Med. 2010;181:116-124.
  2. Wechsler M et al. J Allergy Clin Immunol. 2013 Dec;132(6):1295-302.

Available In: